Global Testosterone Replacement Therapy Market 2016-2020 - Product Image

Global Testosterone Replacement Therapy Market 2016-2020

  • ID: 3802174
  • Report
  • Region: Global
  • 59 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • AbbVie
  • Antares Pharma
  • Eli Lilly
  • Forendo Pharma
  • MetP Pharma
  • ProStrakan
  • MORE
About Testosterone Replacement Therapy

Testosterone replacement therapy, also called androgen replacement therapy, is typically used to treat hypogonadism. Testosterone, a hormone produced by the testes, is responsible for the development of secondary sexual characters in men. The levels of testosterone decrease gradually with age, but sometimes this decline is seen even in young men, leading to a condition known as hypogonadism. This can be treated with external supply of testosterone in the form of gels, patches, injectable, or oral drugs.

The analysts forecast the global testosterone replacement therapy market is gradually declining and will post a CAGR of (3.35) % during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global testosterone replacement therapy market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs that treat and prevent hypogonadism.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Testosterone Replacement Therapy Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- AbbVie
- Allergan
- Eli Lilly and Company
- Endo Pharmaceuticals

Other prominent vendors
- Acerus Pharmaceuticals Corporation
- Antares Pharma
- Bayer HealthCare Pharmaceuticals
- Bedford Labs
- Clarus Therapeutics
- Ferring Pharmaceuticals
- Forendo Pharma
- Juniper Pharmaceuticals
- Lipocine
- MetP Pharma
- Mylan
- Pfizer
- ProStrakan Group
- Repros Therapeutics
- Sandoz
- TesoRx
- Teva Pharmaceuticals

Market drivers
- Increase in older population
- For a full, detailed list, view the full report

Market challenges
- FDA warnings on use of testosterone products
- For a full, detailed list, view the full report

Market trends
- Entry of SARMs
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie
  • Antares Pharma
  • Eli Lilly
  • Forendo Pharma
  • MetP Pharma
  • ProStrakan
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Hypogonadism
  • Understanding Hypergonadism
  • Pathophysiology
  • Symptoms
  • Diagnosis
  • Treatment
PART 06: Pipeline analysis
  • TESTAVAN
  • Vibex QST
  • LPCN 1021
  • REXTORO
  • Enclomiphene
  • LPCN 1111
  • TSX-002
  • TEFINA
  • THG-1001
  • MetP Testosterone Nasal Gel
PART 07: Key buying criteria

PART 08: Market landscape
  • Global endocrinology drugs market
  • Global testosterone replacement therapy market
  • Five forces analysis
PART 09: Market segmentation by dosage form
  • Gels
  • Injectables
  • Patches
  • Others
PART 10: Geographical segmentation
  • Global testosterone replacement therapy market by geography 2015-2020
  • Testosterone replacement therapy market in Americas
  • Testosterone replacement therapy market in EMEA
  • Testosterone replacement therapy market in APAC
PART 11: Market drivers
  • Increase in older population
  • High incidence of testosterone deficiency
  • Rise in chronic diseases
  • Increase in awareness
PART 12: Impact of drivers

PART 13: Market challenges
  • Generic erosion
  • FDA warnings on use of testosterone products
  • Adverse effects
  • Physicians are reluctant to prescribe medications with testosterone
  • Reluctance to discuss condition
PART 14: Impact of drivers and challenges

PART 15: Market trends
  • Entry of SARMs
  • Support of patient assistance programs
  • Focus on emerging markets
  • Application in new therapeutic indications
PART 16: Vendor landscape
  • Competitive scenario
  • Market analysis 2015
  • AbbVie
  • Allergan
  • Eli Lilly
  • Endo International
  • Other prominent vendors
PART 17: Appendix
  • List of abbreviations
PART 18: About the Author

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Normal levels of testosterone based on gender
Exhibit 03: Normal levels of testosterone at different ages
Exhibit 04: Timeline of testosterone replacement therapy products
Exhibit 05: Advantages and risks associated with use of testosterone products
Exhibit 06: Causes of hypogonadism
Exhibit 07: Symptoms of hypogonadism
Exhibit 08: Diagnostic algorithm of hypogonadism
Exhibit 09: Pipeline portfolio: Global testosterone drugs market
Exhibit 10: Key buying criteria for testosterone replacement therapy
Exhibit 11: Global endocrinology drugs market 2015-2020 ($ billions)
Exhibit 12: Market share of global testosterone replacement therapy market in global endocrinology drugs market
Exhibit 13: Global testosterone replacement therapy market 2015-2020 ($ billions)
Exhibit 14: Five forces analysis
Exhibit 15: Global testosterone replacement therapy market by dosage form 2015
Exhibit 16: Segmentation of global testosterone replacement therapy market based on geography 2015
Exhibit 17: Global testosterone replacement therapy market by geography 2015-2020 ($ billions)
Exhibit 18: Global testosterone replacement therapy market by geography 2015-2020
Exhibit 19: Testosterone replacement therapy market in Americas 2015-2020 ($ billions)
Exhibit 20: Percentage share of US in testosterone replacement therapy market 2015
Exhibit 21: Testosterone replacement therapy market in EMEA 2015-2020 ($ billions)
Exhibit 22: Testosterone replacement therapy market in EMEA 2015-2020 ($ billions)
Exhibit 23: Global testosterone replacement therapy market: YoY growth and revenue based on geography 2015-2020
Exhibit 24: Impact of drivers
Exhibit 25: Impact of drivers and challenges
Exhibit 26: AbbVie: YoY revenue and growth rate of AndroGel 2013-2015 ($ billions)
Exhibit 27: AbbVie: Key takeaways
Exhibit 28: Allergan: Key takeaways
Exhibit 29: Eli Lilly: YoY revenue and growth rate of Axiron 2013-2015 ($ millions)
Exhibit 30: Geographical segmentation of Axiron by revenue 2015
Exhibit 31: Eli Lilly: Key takeaways
Exhibit 32: Endo International: YoY revenue and growth rate of Fortesta 2013-2015 ($ millions)
Exhibit 33: Endo: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • AbbVie
  • Antares Pharma
  • Eli Lilly
  • Forendo Pharma
  • MetP Pharma
  • ProStrakan
  • MORE
New Report Released: – Global Testosterone Replacement Therapy Market 2016-2020

The author of the report recognizes the following companies as the key players in the global testosterone replacement therapy market: AbbVie, Allergan, Eli Lilly, and Endo International.

Other Prominent Vendors in the market are: Acerus Pharmaceuticals, Antares Pharma, Bayer HealthCare Pharmaceuticals, Bedford Labs, Clarus Therapeutics, Ferring Pharmaceuticals, Forendo Pharma, Juniper Pharmaceuticals, Lipocine, MetP Pharma, Mylan, Pfizer, ProStrakan, Repros Therapeutics, Sandoz, TesoRx, and Teva Pharmaceuticals.

Commenting on the report, an analyst from the research team said: “Entry of SARMs will be a key trend for market growth. Testosterone therapies available as injectable or skin delivery formulations are currently used as androgen therapies. However, they are associated with side effects related to fluctuations in testosterone levels. The development and entry of SARMs in the market will serve as a better treatment option for androgen deficiencies. These drugs are available as orally active formulations and target androgen receptors specifically, thus eliciting the desired response in the body.”

According to the report, increase in older population will be a key driver for market growth. Age related lowering of testosterone presents features both primary and secondary hypogonadism. Improved healthcare infrastructure and sophisticated treatment facilities have increased life expectancy of individuals. This has led to an increase in older adult population worldwide.

Further, the report states that generic erosion will be a challenge for the market. The entry of generic drugs in the market results in the decline in the overall market revenue, thus affecting the growth of the market. Though all marketed drugs have not lost their respective patents, generic testosterone formulations are available in the market. The branded versions of the drug costs around $300 – $350 per month and generic versions of testosterone shots can be obtained at as low as $20 per dose. Thus, the generic erosion of drugs acts as a challenge for the growth of the market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- AbbVie
- Allergan
- Eli Lilly
- Endo International
- Acerus Pharmaceuticals
- Antares Pharma
- Bayer HealthCare Pharmaceuticals
- Bedford Labs
- Clarus Therapeutics
- Ferring Pharmaceuticals
- Forendo Pharma
- Juniper Pharmaceuticals
- Lipocine
- MetP Pharma
- Mylan
- Pfizer
- ProStrakan
- Repros Therapeutics
- Sandoz
- TesoRx
- Teva Pharmaceuticals
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll